期刊
ALZHEIMERS & DEMENTIA
卷 15, 期 3, 页码 418-428出版社
WILEY
DOI: 10.1016/j.jalz.2018.09.008
关键词
Preclinical Alzheimer's disease; beta-amyloid; Hypertension; Obesity; Depression; Neuropsychology
资金
- National Institutes of Health (NIH) National Center for Advancing Translational Sciences
- National Institute of Child Health and Human Development [P30 HD03352]
- NIH [R01 AG021155, R01 AG027161, ADRC P50 AG033514, R01AG037639, R01 AG054059, F30 AG054115, T32 GM007507, T32 GM008692, T32 CA009206]
- [UL1TR00427]
Background: This study tested if central obesity, hypertension, or depressive symptoms moderated the relationship between beta-amyloid (A beta) and longitudinal cognitive performance in late middle-aged adults enriched for Alzheimer's disease (AD) risk. Methods: Participants (n = 207; ages = 0-70 years; 73% parental AD) in the Wisconsin Registry for Alzheimer's Prevention study completed 3+ neuropsychological evaluations and a [C-11]PiB positron emission tomography scan or lumbar puncture. Linear mixed-effects regression models tested interactions of risk factor X Ab X visit age on longitudinal Verbal Learning & Memory and Speed & Flexibility factor scores. Results: The relationship between Ab and Verbal Learning & Memory decline was moderated by hypertension (chi(2)((1)) = 3.85, P = .04) and obesity (chi(2)((1)) = 6.12, P = .01); those with both elevated Ab and the risk factor declined at faster rates than those with only elevated Ab or elevated risk factors. Conclusion: In this cohort, hypertension and obesity moderated the relationship between Ab and cognitive decline. Published by Elsevier Inc. on behalf of the Alzheimer's Association.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据